Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Serdjebi · SciRah

Researcher profile · Semantic Scholar

C. Serdjebi

Share profile

C. Serdjebi — researcher profile on SciRah

h-index: 16
Works: 44
Citations: 1,089

Most-cited papers

Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment
E. Pasquier, J. Ciccolini, M. Carré, S. Giacometti +6 more
2011OncoTarget226 citations Open access
Semantic Scholar
Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective
J. Ciccolini, C. Serdjebi, G. Peters, E. Giovannetti
2016Cancer Chemotherapy and Pharmacology219 citations Open access
Semantic Scholar
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions
Sonia Brun, Eloïne Bestion, E. Raymond, F. Bassissi +21 more
2021Autophagy91 citations Open access
Semantic Scholar
Role of cytidine deaminase in toxicity and efficacy of nucleosidic analogs
C. Serdjebi, G. Milano, J. Ciccolini
2015Expert Opinion on Drug Metabolism & Toxicology70 citations
Semantic Scholar
EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer
P. Tomasini, C. Serdjebi, N. Khobta, P. Metellus +7 more
2016International Journal of Molecular Sciences67 citations Open access
Semantic Scholar
Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen.
C. Serdjebi, J. Seitz, J. Ciccolini, M. Duluc +5 more
2013Pharmacogenomics (London)41 citations
Semantic Scholar
Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer
M. Bilous, C. Serdjebi, Arnaud Boyer, P. Tomasini +5 more
2019Scientific Reports38 citations Open access
Semantic Scholar
GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma
Sonia Brun, F. Bassissi, C. Serdjebi, M. Novello +8 more
2019Investigational new drugs36 citations
Semantic Scholar
In Vivo Bioluminescence Tomography for Monitoring Breast Tumor Growth and Metastatic Spreading: Comparative Study and Mathematical Modeling
S. Mollard, R. Fanciullino, S. Giacometti, C. Serdjebi +2 more
2016Scientific Reports36 citations Open access
Semantic Scholar
Pharmacokinetics and Pharmacodynamics-Based Mathematical Modeling Identifies an Optimal Protocol for Metronomic Chemotherapy.
J. Ciccolini, D. Barbolosi, C. Meille, A. Lombard +5 more
2017Cancer Research34 citations Open access
Semantic Scholar
Biodistribution, Tumor Uptake and Efficacy of 5-FU-Loaded Liposomes: Why Size Matters
R. Fanciullino, S. Mollard, F. Correard, S. Giacometti +3 more
2014Pharmaceutical Research32 citations
Semantic Scholar
Selection of the Best Blood Compartment to Measure Cytidine Deaminase Activity to Stratify for Optimal Gemcitabine or Cytarabine Treatment
G. Peters, R. Honeywell, Marie Maulandi, E. Giovannetti +5 more
2014Nucleosides, Nucleotides & Nucleic Acids30 citations
Semantic Scholar
Cigarette smoke-induced gasdermin D activation in bronchoalveolar macrophages and bronchial epithelial cells dependently on NLRP3
Sarah Huot-Marchand, Mégane Nascimento, Elodie Culerier, M. Bourenane +10 more
2022Frontiers in Immunology26 citations Open access
Semantic Scholar
Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody
M. Nachit, C. Montemagno, Romain Clerc, M. Ahmadi +9 more
2023Nature Communications25 citations Open access
Semantic Scholar
FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients
C. Serdjebi, J. Gagnière, J. Desramé, F. Fein +16 more
2015PLoS ONE22 citations Open access
Semantic Scholar
Automated whole slide image analysis for a translational quantification of liver fibrosis
C. Serdjebi, Karine Bertotti, Pin-Zhu Huang, G. Wei +6 more
2022Scientific Reports18 citations Open access
Semantic Scholar
Nucleoside analogs: ready to enter the era of precision medicine?
J. Ciccolini, C. Serdjebi, Hau Le Thi Thu, B. Lacarelle +2 more
2016Expert Opinion on Drug Metabolism & Toxicology16 citations
Semantic Scholar
Yin and yang of cytidine deaminase roles in clinical response to azacitidine in the elderly: a pharmacogenetics tale.
R. Fanciullino, C. Mercier, C. Serdjebi, G. Venton +6 more
2015Pharmacogenomics (London)16 citations
Semantic Scholar
Pharmacogenetics and breast cancer management: current status and perspectives
J. Ciccolini, R. Fanciullino, C. Serdjebi, G. Milano
2015Expert Opinion on Drug Metabolism & Toxicology15 citations
Semantic Scholar
Lethal toxicity after administration of azacytidine: implication of the cytidine deaminase-deficiency syndrome.
R. Fanciullino, C. Mercier, C. Serdjebi, Yael Berda +5 more
2015Pharmacogenetics & Genomics11 citations
Semantic Scholar
Computational modeling reveals dynamics of brain metastasis in non-small cell lung cancer and provides a tool for personalized therapy
M. Bilous, C. Serdjebi, Arnaud Boyer, P. Tomasini +5 more
2018bioRxiv6 citations Open access
Semantic Scholar
Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome
Bin Ni, Shanshan Chen, K. Ryan, M. Maitland +10 more
2022Molecular Metabolism4 citations Open access
Semantic Scholar
Population Pharmacokinetics of Gemcitabine and dFdU in Pancreatic Cancer Patients Using an Optimal Design, Sparse Sampling Approach
C. Serdjebi, Florence Gattacceca, J. Seitz, F. Fein +8 more
2017Therapeutic Drug Monitoring4 citations
Semantic Scholar
Recipient/donor contradictory genotypes with impact on drug pharmacogenetics after liver transplant: a deadly gift?
C. Serdjebi, J. Ciccolini, F. Fina, A. Delarue +4 more
2014Pharmacogenetics & Genomics4 citations
Semantic Scholar
Abstract 2208: Cytidine deaminase deficiency and severe toxicities upon aza-cytidine intake: Clinical observations and experimental evidences.
R. Fanciullino, C. Serdjebi, S. Mollard, R. Costello +3 more
20133 citations
Semantic Scholar
Abstract 4506: Computational-driven metronomics: application to gemcitabine in neuroblastoma-bearing mice
J. Ciccolini, E. Pasquier, A. Lombard, S. Giacometti +5 more
20152 citations
Semantic Scholar
Abstract 1869: Severe toxicities in patients undergoing gemcitabine, ARA-C, capecitabine, or azacytidine treatments: Is deregulated cytidine deaminase the bad guy
C. Serdjebi, J. Ciccolini, A. Evrard, C. Mercier +6 more
20121 citations
Semantic Scholar
MorphoQuant, the first fully-automated morphometric software for the assessment of liver biopsy, identified significant differences between non-alcoholic fatty liver disease and steatohepatitis biopsies
C. Serdjebi, B. Lepoivre, Florine Chandes, Linda Willis +1 more
2023Journal of Hepatology0 citations
Semantic Scholar
Dual High-throughput, Automated Analysis of Histomorphometric Markers of Fibrosis and Emphysema in Two Bleomycin-induced Mouse Models of Idiopathic Pulmonary Fibrosis
C. Serdjebi, A. G. Petersen, F. Chandes, D. Oró +4 more
2023D29. TRANSLATIONAL RESEARCH IN IPF0 citations
Semantic Scholar
Morphometric analysis of sonic hedgehog in non-alcoholic fatty liver steatohepatitis patients by MorphoQuant: a potential biomarker of disease severity
C. Serdjebi, B. Lepoivre, Florine Chandes, Linda Willis +1 more
2023Journal of Hepatology0 citations
Semantic Scholar
High-throughput, Automated Analysis of Blood Vessel Histomorphometry in Two Rat Models of Pulmonary Arterial Hypertension
C. Serdjebi, C. Laurent, M. Berniac, B. Lepoivre +3 more
2023B56. -OMICS, MACHINES, AND DEVICES IN PULMONARY HYPERTENSION0 citations
Semantic Scholar
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular 1 carcinoma via modulation of lysosomal functions 2
Sonia Brun, Eric Raymond, F. Bassissi, Z. Jílková +21 more
20200 citations
Semantic Scholar
Abstract 899: Remarkable anti-tumor response in a HCC transgenic mouse model treated with GNS561 in combination with anti-PD1
M. Rachid, A. Tijeras-Raballand, C. Serdjebi, Sonia Brun +3 more
2020Immunology0 citations
Semantic Scholar
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions
Sonia Brun, Eric Raymond, F. Bassissi, Z. Jílková +21 more
2020bioRxiv0 citations Open access
Semantic Scholar
GNS561 ALONE OR IN COMBINATION WITH CISPLATIN OR GEMCITABINE FOR THE TREATMENT OF INTRAHEPATIC CHOLANGIOCARCINOMA
Sonia Brun, C. Ansaldi, F. Bassissi, C. Serdjebi +9 more
20190 citations
Semantic Scholar
Preliminary safety and pharmacokinetics of a new lysosomotropic oral agent, GNS561, in a first-in-human study in advanced primary liver cancer patients
A. Awada, J. Harding, N. Kotecki, P. Aftimos +8 more
2019Annals of Oncology0 citations Open access
Semantic Scholar
GNS561, A NEW ORAL CLINICAL-STAGE SMALL MOLECULE COMBINED WITH ANTI-PD1 SHOWED REMARKABLE ANTI-TUMOR EFFECTS IN A TRANSGENIC IMMUNOCOMPETENT HEPATOCELLULAR CARCINOMA MOUSE MODEL (ASV-B)
M. Rachid, A. Tijeras-Raballand, C. Serdjebi, Sonia Brun +3 more
20190 citations
Semantic Scholar
Abstract 5479: PGx of gemcitabine in pancreatic ADK: Where did we go wrong
C. Serdjebi, Florence Gattacceca, Martina Schneider, C. Montérymard +7 more
20150 citations
Semantic Scholar
Ang1 and Tie2 Are Predictive Biomarkers for Bevacizumab—Letter
J. Ciccolini, C. Serdjebi, D. Barbolosi, B. Lacarelle +1 more
2015Clinical Cancer Research0 citations Open access
Semantic Scholar
Abstract 5549: Recipient-donor contradictory genotype with impact on anticancer drug pharmacogenetics after liver transplant: A deadly gift
C. Serdjebi, R. Fanciullino, F. Fina, Arnaud Verschuur +5 more
20140 citations
Semantic Scholar
Biodistribution, Tumor Uptake and Efficacy of 5-FU-Loaded Liposomes: Why Size Matters
R. Fanciullino, S. Mollard, F. Correard, S. Giacometti +3 more
2014Pharmaceutical Research0 citations
Semantic Scholar
Cytidine deaminase status as a predictive marker in patients with hematologic malignancies treated with azacytidine or cytarabine.
C. Mercier, R. Fanciullino, C. Serdjebi, J. Ciccolini +4 more
20130 citations
Semantic Scholar
Cytidine Deaminase Status As a Predictive Marker Of Response and Toxicity In Patients With Haematological Malignancies Treated With Azacytidine Or Cytarabine
C. Mercier, R. Fanciullino, C. Serdjebi, J. Ciccolini +4 more
20130 citations
Semantic Scholar
Abstract 2555: Drug repositioning: Propanolol potentiates the anticancer efficacy of chemotherapeutic agents through modulation of angiogenesis
J. Ciccolini, E. Pasquier, R. Fanciullino, C. Serdjebi +4 more
20110 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Ciccolini×24
Invite
J. Ciccolini — researcher profile on SciRah
R. Fanciullino×14
Invite
R. Fanciullino — researcher profile on SciRah
L. Ouafik×10
Invite
L. Ouafik — researcher profile on SciRah
B. Lacarelle×10
Invite
B. Lacarelle — researcher profile on SciRah

×9

Invite

M. Rachid — researcher profile on SciRah

Invite

C. Ansaldi — researcher profile on SciRah

S. Giacometti×7

Invite

S. Giacometti — researcher profile on SciRah

Invite

N. André — researcher profile on SciRah

Invite

Sonia Brun — researcher profile on SciRah

Invite

P. Halfon — researcher profile on SciRah

Invite

G. Milano — researcher profile on SciRah

Invite

E. Raymond — researcher profile on SciRah